Preclinical Evaluation of Cudetaxestat for Potential Drug-Drug Interactions

被引：0
|
作者：
Yu, W. [1 ]
Rajagopalan, R. [1 ]
Lin, J. [1 ]
Ibrahim, P. [1 ]
机构：
[1] Blade Therapeut Inc, San Francisco, CA USA
来源：
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE | 2022年 / 205卷
关键词：
D O I：
暂无
中图分类号：
R4 [临床医学];
学科分类号：
1002 ; 100602 ;
摘要：
A2719
引用
收藏
页数：1
相关论文
共 50 条
  • [41] Data mining for potential adverse drug-drug interactions
    Hammann, Felix
    Drewe, Juergen
    [J]. EXPERT OPINION ON DRUG METABOLISM & TOXICOLOGY, 2014, 10 (05) : 665 - 671
  • [42] Analysis of potential drug-drug interactions in hospitalized patients
    Wieczorek, M.
    [J]. INTERNATIONAL JOURNAL OF CLINICAL PHARMACY, 2022, 44 (06) : 1550 - 1550
  • [43] Clinical Pharmacokinetics of Cannabinoids and Potential Drug-Drug Interactions
    Vazquez, Marta
    Garcia-Carnelli, Carlos
    Maldonado, Cecilia
    Fagiolino, Pietro
    [J]. CANNABINOIDS AND SLEEP: MOLECULAR, FUNCTIONAL AND CLINICAL ASPECTS, 2021, 1297 : 27 - 42
  • [44] Milnacipran Has Low Potential for Drug-Drug Interactions
    Periclou, Antonia
    Coutts, Stephen M.
    Rao, Sriniuas G.
    Palmer, Robert H.
    Thacker, Kim
    Trugman, Joel
    [J]. NEUROLOGY, 2009, 72 (11) : A212 - A212
  • [45] Potential severe drug-drug interactions in elderly patients
    [J]. Reactions Weekly, 2021, 1879 (1) : 9 - 9
  • [46] A Minimal Information Model for Potential Drug-Drug Interactions
    Hochheiser, Harry
    Jing, Xia
    Garcia, Elizabeth A.
    Ayvaz, Serkan
    Sahay, Ratnesh
    Dumontier, Michel
    Banda, Juan M.
    Beyan, Oya
    Brochhausen, Mathias
    Draper, Evan
    Habiel, Sam
    Hassanzadeh, Oktie
    Herrero-Zazo, Maria
    Hocum, Brian
    Horn, John
    LeBaron, Brian
    Malone, Daniel C.
    Nytro, Oystein
    Reese, Thomas
    Romagnoli, Katrina
    Schneider, Jodi
    Zhang, Louisa
    Boyce, Richard D.
    [J]. FRONTIERS IN PHARMACOLOGY, 2021, 11
  • [47] TERIFLUNOMIDE: POTENTIAL FOR TRANSPORTER MEDIATED DRUG-DRUG INTERACTIONS
    Weitz, D.
    Schmider, W.
    Menguy-Vacheron, F.
    Clot, P.
    Hermabessiere, S.
    Jiang, J.
    Su, Y.
    Thuillier, V.
    Turpault, S.
    [J]. CLINICAL PHARMACOLOGY & THERAPEUTICS, 2013, 93 : S112 - S113
  • [48] The serotonin syndrome, triptans, and the potential for drug-drug interactions
    Shapiro, Robert E.
    Tepper, Stewart J.
    [J]. HEADACHE, 2007, 47 (02): : 266 - 269
  • [49] DRUG-DRUG INTERACTIONS
    FORTH, W
    [J]. ARZNEIMITTEL-FORSCHUNG/DRUG RESEARCH, 1976, 26 (NA1): : 108 - 114
  • [50] Characterization and Preclinical Perspectives of Organic Small Molecule Drug Metabolites in Drug-drug Interactions
    Gao, Liqian
    Chen, Jun
    Hu, Yi
    Sun, Hongyan
    Ong, Yong Siang
    Zhang, Jingxin
    Chai, Zhifang
    Lee, Su Seong
    [J]. CURRENT ORGANIC CHEMISTRY, 2016, 20 (17) : 1827 - 1834
12345